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Atrial natriuretic peptide and cGMP inhibit Na/H antiporter In
vascular smooth muscle cells in culture. The aim of the present paper was
to study the mechanisms of the inhibitory effect of atrial natriuretic
peptide (ANP) on the sustained contraction phase of vascular smooth
muscle cells (VSMC). Specifically, the potential role of ANP on the
Na/H antiporter and Na transport systems was investigated. Both
ANP and 8-bromo cGMP inhibited 22Na uptake and decreased intra-
cellular Na ([Na]) in VSMC, an effect that was mimicked by the
specific Na/H antiporter inhibitor, hexamethylen amiloride (HMA).
The effect of ANP was not additive with HMA, therefore suggesting
that both inhibit the same 22Na transport pathway. On the other hand,
the inhibition of 22Na accumulation by ANP was additive with the
inhibition by furosemide or bumetanide, thus suggesting that both drugs
act on different Na exchange systems. In HEPES-buffered medium,
ANP, cGMP, and HMA significantly inhibited the AVP-induced intra-
cellular alkalinization, an effect which was associated with significant
inhibition of the AVP-induced shape change. In bicarbonate buffered
medium, ANP and cGMP decreased the pH level below the baseline
after application of AVP, and an inhibition by ANP and cGMP of
AVP-induced VSMC shape change was also observed. The recovery of
cellular pH after three different types of acid load, namely, ammonium
chloride pulse, nigericin clamp and lowering of extracellular pH, was
significantly decreased by ANP and cGMP. Taken together, these
results indicate that ANP/cGMP inhibit the activity of the Na/H
antiporter in VSMC, either in hormone- or pH-stimulated conditions.
Atrial natriuretic peptide (ANP) is known to cause vasodila-
tion in vivo, an effect which is most pronounced in the presence
of elevated plasma concentrations of endogenous vasoconstric-
tor hormones such as angiotensin, norepinephrine and arginine
vasopressin (AVP). This interaction may occur most promi-
nently in advanced cardiac failure, since both plasma ANP and
endogenous vasoconstrictors are elevated in that setting [1].
The cellular mechanisms whereby ANP attenuates the vaso-
constrictor effects of endogenous pressor agents, however, has
not been completely defined. Studies from several laboratories
including ours [2—5] have shown that the initial pressor-induced
rise in cytosolic-free Ca2 ([Ca2i,) and enhanced Ca2 efflux
are significantly attenuated by ANP (that is, atriopeptin III).
While these cellular events are known to be associated with
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early, rapid contraction of vascular smooth muscle cells
(VSMC), the more sustained phase of contraction involves
additional mechanisms. In this regard, our previous studies
demonstrated a potent effect of ANP to block AVP-induced
sustained VSMC contraction, a protein kinase C-related pro-
cess that can be mimicked by using phorbol esters [6].
Further studies therefore were needed to examine the effect
of ANP and its second messenger, cUMP, on pressor-induced
sustained VSMC contraction and the accompanying cellular
events including alterations in ion transport. Although an inhib-
itory effect of ANP or cGMP on Na uptake and NafH
exchange has been found in renal tubular and intestinal epithe-
hal cells [7—9], these effects have not been sufficiently substan-
tiated in nonepithelial, VSMC cells.
The present study was therefore undertaken to further exam-
ine the cellular mechanisms whereby ANP interacts with ionic
transport systems which are involved in the AVP-induced
sustained VSMC contraction. The focus of these studies, which
were performed in VSMC in culture, was on the alterations in
Na and H ion transport in different experimental conditions.
Methods
8-Bromo cGMP, ANP (rat atriopeptin III), amiloride, fu-
rosemide, bumetanide, and isobutylmethylxanthine (IBMX)
were purchased from Sigma Chemical Co. (St. Louis, Missouri,
USA); 22Na was purchased from New England Nuclear (Bos-
ton, Massachusetts, USA). Hexamethylen amiloride (HMA)
and ethylisopropyl amioride (EIPA) were provided by Dr. E.J.
Cragoe, Jr. The pH and [Na]1 probes 2',7'-bis-(2-carboxym-
ethyl)-5 (and -6) carboxyl fluorescein acetoxymethyl ester
(BCECF/AM), benzofuran isophtalate acetoxymethyl ester
(SBFIIAM) and pluronic acid were purchased from Molecular
Probes (Eugene, Oregon, USA). The kits for the cGMP and
3H-AVP determinations were purchased from New England
Nuclear. The analog of cGMP, 8-bromo cGMP, was used in all
experiments in which it was administered exogenously and
therefore it is referred to as cGMP or 8-bromo cGMP through-
out the manuscript. In the same regard, ANP is mostly used
instead of atriopeptin III.
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Cell culture
Rat aorta VSMC were cultured on 35 mm plastic tissue
culture dishes and glass coverslips as previously described
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[4, 6, 10—12]. Cells were fed with MEM-Eagle's medium + 10%
fetal calf serum (FCS). Subcultures were obtained by treating
the cells with Trypsin-EDTA [10—121. Cells were used for
experiments when they reached a confluent state, approxi-
mately between 8 and 12 days after plating. VSMC were used
from cultures of one to three passages. Using this or similar
culture conditions, VSMC have been shown to possess activity
of several cationic-exchange systems, that is, Na/H [6,
13—16], Na/Ca2 [17—19], Ca2-ATPase and Ca2-activated
K channels [5, 17, 20—22], Na,K,Cl co-transporter [22],
Na/K-ATPase [12], and at least two types of voltage regu-
lated channels [23]. VSMC in culture also respond to pressor
hormones, such as AVP, with a characteristic pattern of intra-
cellular Ca2 and pH changes [4, 10, 24, 25]. The relative
contribution of each one of these transport systems to the
intracellular ionic composition in VSMC has not yet been
precisely established in physiological conditions; in fact, the
contribution of each particular transport system to the overall
ionic equilibrium in VSMC is actually highly dependent of the
particular experimental conditions.
22Na uptake
22Na uptake was measured by a modification of the methods
as previously described by Cantiello and Ausiello [24], Berk et
al [25], and Vigne, Frelin and Lazdunski [26]. Briefly, after
washing three times with a Na-free, choline chloride isosmotic
medium, cells were preincubated for 30 minutes in the same
isosmotic medium (140 m choline chloride, 1.8 mM CaCl2, 5
mM KC1, 0.8 mri MgSO4, 5 mrt glucose, 25 mi HEPES, Tris
base, pH 7.0, and 0.5 mrvi ouabain) to deplete intracellular Nat
After the preincubation period the VSMC were transferred to a
similar medium with different concentrations of NaC1 (0 to 140
mM, pH 7.4), made isosmotic with a solution of choline chloride
containing 1 CiIml of 22Na and 0.5 mrvi ouabain plus the
agents to be tested. The 22Na uptake increased linearly with
Na concentration in the range of extracellular [Na] of 0 to
140 mrs. 22Na uptake was interrupted at different times by
washing the cells in two different beakers containing 25 ml of
ice-cold 0.1 M MgC12. Cells were lysed by using sodium dodecyl
sulphate (SDS) solution (0.1% SDS, 2.0% Na2CO3, 0.1 N
NaOH), and samples were used for scintillation counting (beta-
emission), gamma-counting and protein determination [27]. All
the incubation procedures were performed in triplicate or
quadruplicate at room atmosphere, using a shaking bath at
37°C. In different experiments, ANP, cGMP, amioride, HMA,
furosemide, or bumetanide were added during the last five
minutes of the preincubation period and throughout the entire
incubation period. With each group of experiments comparing
basal, ANP or cGMP effects, cells from the same culture and
passage were used to avoid any heterogeneity due to variations
between cultures.
The results were expressed as cpm mg protein1. As pre-
dicted, values from the beta-emission counting were strictly
proportional to those obtained for gamma-emission, therefore
only the latter were used for the expression of the results. For
most of the experiments in which the effect of the different
agents was examined, an incubation time of 30 minutes was
used. This was based on preliminary determinations in which
isotope equilibrium was attained after 20 minutes.
Measurement of[Na
[Na], was measured as described by Okada et al [28]. The
VSMC monolayers were washed twice with physiological saline
solution [PSS (in mM): 140 NaC1, 4.6 KC1, 1.0 MgC12, 2.0
CaC12, 10 glucose, 10 N-2-hydroxyethylpiperazine-N'-2-ethane-
sulfonic acid (HEPES), pH 7.4] and loaded with 10 pM sodium-
binding benzofuran isophthalate acetoxy-methyl ester (SB F!!
AM; Molecular Probes, Eugene, Oregon) for three hours at
37°C. SBFI was dissolved in PSS containing 0.02% pluronic
F-127, a nonionic surfactant. After the loading period, the cells
were washed three times with PSS and placed in a 1 X 1-cm
quartz cuvette containing 1 ml of PSS at 37°C. The fluorescent
intensity was measured by a Perkin-Elmer fluorescent spectro-
photometer (Model LS 50), using the excitation wavelengths
340 and 380 nm and an emission wavelength of 500 nm. [Na]1
was calibrated by equilibrating [Na11 with the extracellular
Na concentration using 1 x 10—6 M gramicidin. The reference
standard solution was made from appropriate mixtures of Na
and K which were adjusted to 145 m (total Na + K). Two
types of experiments were done using the SBFI technique. The
cells were exposed to AVP (10 M) or shifted to a 140 mrt NaC1
medium after a 30 minute preincubation in a non-Na medium,
using conditions and buffers identical to the 22Na uptake
experiments. Both types of experiments were done either with
or without preincubation with ANP (10 M).
22Na + efflux
After washing three times with a Na-free, choline chloride
isosmotic medium, cells were preincubated for 15 minutes in
the same isosmotic medium to deplete intracellular Nat After
15 minutes, the cells were loaded with 3 tCi 22Na in the same
medium as described for 22Na uptake. After two hours, the
cells were rapidly rinsed 10 times with PSS-Ca2 buffer. One ml
of PSS-Ca2 was added to initiate efflux. The ml of buffer was
removed and replaced every minute during eight minutes.
22Na in the efflux buffer was measured by liquid scintillation
counting. At the end of the experiment cells were washed three
times with ice-cold 0.1 M MgC12. Cells were lysed by 10% TCA
and samples were taken for scintillation counting (beta-emis-
sion) and protein determination. The data are represented as
percentage of counts in the supernatant with respect to the total
content of 22Na within the cells.
Intracellular pH measurement
Intracellular pH was measured by the fluorescent indicator
BCECF-AM [6, 27]. In one type of experiments the monolayers
grown on glass coverslips were washed twice with PSS and
incubated with PSS containing 2 tM BCECF-AM for 60 min-
utes at 37°C. At the end of the loading period, the cells were
washed three times with PSS and inserted into glass cuvettes
containing 2 ml of PSS at 37°C. In a second type of experiments,
all the procedures were similar, except for the use of HCO3/C02
buffer (in m, 140 NaCI, 5 KC1, 1.18 KH2PO4, 1.18 MgSO4, 2.5
CaC12, 25 NaHCO3, 10 glucose, equilibrated with 5% C02195%
02 at pH 7.4) instead of PSS. The rationale for the use of these
two buffers is based on the different response observed in each
one of them during the occurrence or not of AVP-induced
intracellular alkalinization [16, 29]. The fluorescent intensity
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was measured by a Perkin-Elmer fluorescent spectrophotome-
ter (Model 650-los), using the excitation wavelengths 455 and
505 nm and an emission wavelength of 530 nm. The ratio of the
fluorescence of the cells at 505/455 nm emitted at 530 nm
permitted the calculation of [pH]1. The fluorescent signal was
calibrated by using varied pH in PSS buffer containing the
K/H ionophore nigencin (10 g/ml) [61. In additional series
of experiments, the VSMC were submitted to an acidification
procedure, to measure the rate of recovery of the intracellular
pH. The intracellular acidification was obtained by three differ-
ent procedures: (a) 20 mr'i C1NH4 prepulse (20 mm); (b)
Nigericin acidification technique, clamping the intracellular pH
at 6.8 (30 sec); (c) change in extracellular pH (PSS 6.65, 20 mm).
The recovery from the acid load was undertaken by replacing
the extracellular medium with PSS pH 7.4, with or without
ANP i0 M, cGMP iO M and EIPA iO M.
Receptor binding
All binding studies were performed by using confluent,
monolayer VSMC on 35 x 10 mm culture dishes. The AVP
receptor binding was examined using a method [30] modified
from that described by Fishman et al [31]. The culture medium
was aspirated and the cells were rinsed twice with 2 ml of
binding buffer (25 mrs HEPES, 119.2 mi NaCl, 3 mM KC1, 1.2
mM MgSO, 1 m CaC12, 1.2 mM KH2PO4, 10 m glucose, and
0.1% bovine serum albumin, pH 7.4). The cells were incubated
with 2 x i0 M 3H-AVP in the absence or presence of cold
AVP (1 x 10_6 M) for experimental periods at 4°C. Incubations
were performed in baseline conditions and in the presence of
ANP or amiloride analogues, to ascertain the role of these
agents on AVP binding kinetics. At the end of the incubation,
the reaction mixture was aspirated and the cells were rinsed
four times with 2 ml ice-cold medium. One ml of 0.1% SDS in
0.1 N NaOH was added to solubilize the cells. Samples (100 pi)
were stored for protein assay [27]. The radioactivity of solubi-
lized cells was measured by scintillation counting.
cGMP measurements
As previously described [5] the cells were incubated for 10
minutes at 37°C in the presence of ANP and the cyclic nude-
otide phosphodiesterase inhibitor IBMX (0.5 mM). Incubations
were carried out under the conditions used for the Na uptake
studies. At the end of the incubation period, the incubation
solution was aspirated off, and cells were extracted for 12 hours
at 4°C with a 49:1 (vol/vol) mixture of ethanol/HC1 0.1 N.
Extracts were evaporated using a speed vac evaporator (Model
VR-1/120/240, Heto Lab. Equipment A/S, Denmark). cGMP
was quantified by radioimmunoassay (New England Nuclear).
Vascular smooth muscle cells shape change
VSMC shape change was assessed on primary and first
passage cultures by quantitation of cell surface area changes
using phase-contrast microscopy (Carl Zeiss, IM 35) and a
computerized image analyzer (Zidas, Carl Zeiss) as previously
reported by our laboratory [4,6]. At the time of the experiment,
culture media was aspirated and the cells were washed twice
with PSS. Similar experiments were done in C03H/C02 buffer
(for composition see section on pH measurements), to analyze
the characteristics of the shape-change phenomenon by AVP in
conditions in which no intracellular alkalinization occurs [16,
29]. Cells were incubated with buffer in the absence of the agent
to be tested, and baseline measurements were made and pho-
tographs were taken on a representative field of cells. At 10
minutes after the addition of AVP, the same cells were mea-
sured with the image analyzer and photographs were again
taken. Five measurements of each cell were obtained and
statistically evaluated; any group of measurements showing a
standard deviation of >20% of the mean was discarded. The
results of contraction experiments computerized by the image
analyzer were virtually superimposable with the photographic
results. A value of three times the maximal observed sponta-
neous shape changes (5%) was chosen as representing a signif-
icant degree of VSMC shape change. The results were ex-
pressed as a percent of cells with >15% decrease in surface
area. When the effect of HMA was studied, the cells were
preincubated for 10 minutes in the presence of these agents.
Some special characteristics of the studies on culture systems
should be considered at the time of interpreting the results to
understand possible differences with respect to whole tissue
experiments. The cell shape changes on the culture occur by
sliding of cells on a planar surface, instead of the normal
arrangement of VSMC in the vessels. The conditions of cell-to-
cell communication are also different in the culture cells than in
the vessel. These two reasons account for the VSMC shape
change being mostly an "all or nothing" phenomenon that
maximally affects nearly 45% of the cell culture on a plastic
surface. However, in spite of the putative differences between
the VSMC in culture and in whole vessels, there are several
advantages for using VSMC in culture as an experimental
model. For example, with the VSMC culture there is an
absence of interference by other cell types, that is, blood or
endothelial cells. Furthermore, with VSMC cultures, results
comparing a functional parameter, that is, cell shape changes,
with the measurement of the intracellular mediators involved in
signal transmission are more readily obtained.
Statistical analysis
Results are expressed as mean SEM. The unpaired Stu-
dent's t-test, ANOVA and chi square were used for the statis-
tical comparisons. A P value of less than 0.05 was considered
significant.
Results
Effect of ANP andcGMP on 22Na uptake in VSMC
As shown in Figure 1, ANP and cGMP significantly de-
creased the 22Na uptake in VSMC. A similar result was
obtained using cGMP (10 M; N = 8, P < 0.05, data not
shown). Significant inhibition of 22Na uptake by ANP was
detected from 30 seconds of incubation (Fig. 1 inset). This effect
of ANP on 22Na uptake was concentration-dependent and was
first detected with 10— 10 M ANP and l0— M cGMP (Fig. 2). The
maximal effect of ANP was at l0 M, since 10—6 M ANP
produced the same degree of inhibition of Na uptake (29.7% at
30 mm, P = NS with respect to iO M ANP).
Effect of amiloride and amiloride analogues on ANP-
mediated inhibition of 22Na uptake in VSMC
Maximal concentrations of amiloride (10 M) caused a
significant decrease in 22Na uptake in VSMC (Fig. 3). The
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addition of ANP did not enhance this amiloride-induced decre-
ment in 22Na uptake. Since amiloride may conceal the effect of
ANP to decrease 22Na in VSMC by either blocking Na
channels or inhibiting the NafH antiporter, studies were
undertaken using HMA, a specific inhibitor of the NaIH
antiporter. A time profile of 22Na uptake inhibition similar to
that of ANP was observed using l0 M HMA (% inhibition
22Na uptake: 24 4, 25 5, 30 3, 34 6, 36 6 at 30 sec,
1 mm, 2 mm, 5 mm, and 30 mm, respectively; P < 0.05 for all
of the values). The fact that a decrease of 22Na content was
detected with both ANP and HMA at times between 30 seconds
and two minutes suggested that the primary effect was on 22Na
uptake, since no significant efflux of 22Na is expected at such
a short time of the experiment. In fact, the rate of 22Na efflux
was identical with respect to the baseline (slope 2.9 X 102
cpmlmin), either with ANP (l0 M, slope 2.48 x 102 cpmlmin),
HMA (l0 M, slope 2.55 x 10 cpmlmmn) or both together
(slope 2.67 x 102 cpmlmin).
ANP (l0— M) and HMA (4Ø_6 M), the specific inhibitor of the
NaIH antiporter [32], decreased 22Na uptake in VSMC to a
comparable degree (Fig. 4). Moreover, the maximal effects of
ANP (106 M) and HMA (l0— to l0_6 M) were not additive, a
finding compatible with a common mechanism of action. The
maximal effects of ANP, HMA or both to inhibit 22Na uptake
in VSMC were significantly less than the maximal effect of
amiloride (Figs. 3 and 4). This finding suggests that amiloride
(l0 M) decreases 22Na uptake in VSMC 22Na transport by
Fig. 1. ANP (1O— M) decreased 22Na
accumulation in VSMC. Symbols are: (•)
control; (•) ANP. ANP (10—v M) was
present for the last 5 mm of the
preincubation in the Na-free, choline
chloride buffer and during the incubation in
NaC1 (0 to 140 mM) buffer (30 mm). The
results are expressed as mean SEM and
correspond to a minimum of six triplicate or
quadruplicate experiments. Inset shows the
time course of the 22Na uptake in the
presence or absence of ANP (10—v M). The
inhibitory effect of ANP was evident at all
times of the incubation from 30 to 300
seconds. The ordinate axis in the inset is the
same as that in the main figure. A 65 mM
extracellular Na concentration has been
used for the experiments in the inset.
*p < 0.05 compared to control.
—10 —9
—8 —7 ANP
-6 -5 —4 -3CGMP
—Log, M
Fig. 2. Concentration-response curve of the decrease in22Na uptake
by ANP (•) or cGMP (N). The conditions and concentrations were
similar to those described in Figure 1 (N = 5 triplicate experiments). In
this and the following Figures 3, 4 and 5, the extracellular Na
concentration was 3 mti. All decrements for ANP and cGMP at each
dose were significantly (P < 0.05) different as compared to the control
22Na uptake, except for the 106 M cGMP concentration (P < 0.06).
mechanisms in addition to its effect on the Na/H antiporter.
The i0 M concentration of amilonde is about 2.9 x io higher
than the Ki for the Na channel and 12 times higher than the Ki
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for the Na/K antiporter. Also, a significant degree of inhibi-
tion of the Na/Ca2 exchange occurs with amiloride (10—s M)
[32, 33]. HMA (10—s to 10—6 M) amply inhibits the NafH
antiporter (Ki 0.16 M) [32, 33].
Comparison of inhibition of Na,K,Ct co-transporter and
ANP on 22Na uptake in VSMC
Although ANP and furosemide, an inhibitor of the
Na ,K ,C1 co-transporter, decreased 22Na uptake in VSMC
to a comparable degree, the effect of these agents appeared to
be mediated by different mechanisms (Fig. 5). Specifically, the
effects of ANP and furosemide were additive on VSMC 22Na
uptake. Similar effects were obtained when bumetanide (10—i
M) was substituted for furosemide (10—s data not shown). It
should be noted that under the conditions of the present
experiments, the Na ,K ,C1 co-transporter functions in the
direction of a net cellular 22Na gain.
Effect of ANP and cGMP on cytosolic Na levels
As shown by illustrative traces (Fig. 6), the presence of ANP
(10—v M) significantly inhibited the [Na]-increasing effect of
AVP (10—8 M). The mean degree of such inhibition at 300
seconds was 64 4.7% (P <0.001, N = 8). Further experi-
ments were performed in Na-depleted cells to study the
recovery of the [Na]1 in the presence or the absence of iO M
ANP. As shown in Figure 7, i0M ANP significantly inhibited
the recovery of [Nai. These experiments thus support the
effect of ANP observed in the 22Na uptake experiments.
Intracellular pH measurements
Experiments assessing VSMC pH were conducted to further
ascertain the possible effect of ANP and cGMP on the NafH
antiporter. As shown in Figure 8, ANP significantly inhibited
the alkalinization phase of the pH response of VSMC to AVP.
Similar results were obtained with cGMP (10 M) and with
HMA (10—s and 10_6 data not shown). In the absence of
IBMX, this effect on VSMC pH was detected from 10_8 M ANP
and iO M cGMP. In similar experiments performed in
C03H/C02 buffer, ANP (10 M) and HMA (10-s M) signifi-
cantly altered the profile of intracellular pH after challenging
with AVP (10 M), as shown in Table 1.
As shown in Table 2, ANP and amiloride induced a significant
decline in intracellular pH during the 10 minute period of
observation. Similar results were obtained with cGMP but this
decrease in VSMC pH did not reach statistical significance in
the 10 minute period (data not shown). Amioride (10 M) also
blocked the AVP-induced alkalinization (data not shown) [6].
Three types of acidification experiments were performed to
assess whether ANP or cGMP were able to inhibit the recovery
of intracellular pH. In the three types, a significant inhibition of
pH recovery was found (Figs. 9, 10 and 11). In the first two,
ANP was used as the Na/H inhibitory agent (Figs. 9 and 10),
whereas in the third (Fig. 11) we used cGMP to avoid the
putative interference of ANP binding by the acidic extracellular
pH [34]. An inhibitory effect of ANP on the recovery of
acidification was detected in the three types of experiments.
The time profile of these experiments was compatible with the
findings obtained in the Na uptake studies (Figs. 9, 10 and 11).
In this regard, since the preincubation in non-Na-medium
produces an intracellular acidification, both types of experi-
ments may in part illustrate a similar mechanism of Na
entrance. The concentration/response curve of the intracellular
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furosemide (1O- M) with the effect of ANP on 22Na uptake in VSMC.
100
a
az 60
0
C
40
20
0
Amiloride Amfioride + ANP
Fig. 3. Absence of additive effect of ANP (1O M) to Na transport
blockade by amiloride (1O— M).
40
a
20
. 10
0
Fig. 4. Comparison of specic inhibition of Na/H antiporter with
effect of ANP (1O M) andHMA (1O M) on 22Na uptake in VSMC.
Absence of additive effect of both compounds.
ANP Furosemide ANP +
ANP HMA ANP
+ HMA
Caramelo et a!: Na+IH* antiporter in VSMC 71
0
Ce
0
0 20 40 60 80 100120 140160180200220240260280300
Time, seconds
Fig. 6. (A) Representative trace of fNaj1 increase measured by the
SBFI method, after challenge the VSMC with 10—8 M AVP. (B)
Representative trace of an experiment similar to that illustrated in A,
but with AVP (10_8 at) challenging after preincubation (10 mm) with
iO M ANP.
pH recovery (nigericin method) differed if the experiments were
done in the presence or in the absence of the phosphodiesterase
inhibitor, IBMX (Fig. 12). Results on pH recovery experiments
(ammonium chloride method) similar to those observed with
ANP, were obtained with cGMP (10 M) and HMA (10 M)
(P = NS with respect to ANP, data not shown).
cGMP measurements
Determinations of the intracellular cGMP content were per-
formed to ascertain the effect of the different conditions used in
the above experiments on the basal levels of cGMP and the
effect of ANP to increase cGMP. No significant changes in
ANP-induced cGMP production by any of the experimental
maneuvers were detected. In this regard, baseline and ANP-
stimulated values of cGMP in VSMC submitted to the Na
depletion/Na reintroduction maneuvers were 5.94 0.26
(control) versus 68.3 3.2 fmollmg protein (10—v M ANP, p <
0.001 with respect to the baseline). In control cells, baseline and
ANP-stimulated values were 6.48 0.56 and 76.7 4.8
fmollmg (P <0.001 with respect to the baseline, P = NS with
Time, seconds
Fig. 7. Effect of ANP (10—i M) on the recovery of [NaJ1 (mM) after
exposing the cells for 30 mm to PSS with 0 NaCl and reintroducing
NaCI at afinal concentration of 140 m. Symbols are: () control; (5)
ANP. *D < 0.05 between curves.
Fig. 8. Inhibition by ANP (10-i M) of the A VP-induced intracellular
alkalinization in VSMC. The inhibitory effect of ANP was statistically
significant (P < 0.01) from minutes 4 to 10 for the two concentrations of
AVP (10-8 and iO at) used in the experiments. Experiments were
done in HEPES-buffered PSS (pH 7.4) at 37°C, in room atmosphere.
Symbols are: (O----O) AVP (10-8 M); (S •) AVP (10_8 M) + ANP(l0- M); (L----/) AVP (10 M); (A A) AVP (10 M) + ANP
(10-v M).
respect to the 0 Na1140 Na conditions). cGMP production was
in a range similar to the study by Vroux et al [5].
Vascular smooth muscle cells shape change
The effect of AVP (10-8 M) on VSMC shape change (%) was
significantly inhibited in the presence of l0 M HMA (AVP
alone: 23.6 4.2 shape-changing cells, N = 331 cells in 13
different experiments; AVP ÷ HMA: 12.3 3.5 shape-changing
cells, N = 308 cells, in 12 different experiments, P < 0.05). A
similar inhibition of VSMC shape change was found with iO—
M EIPA (AVP + EIPA: 11.7 1.4 shape-changing cells, N = Si
A
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0mm 2mm 5mm
AVP (10—8 M) (N = 5)
AVP (10—8 M) + ANP(l0 M) (N = 5)
AVP (10—8 M) + HMA
(10 M) (N = 3)
7.33 0.05
7.34 0.03
7.30 0.05
7.32 0.03
7.27 0.03
7.24 0.04
7.32 0.03
7.23 0.02
7.18 o.o3
a P < 0.05 with respect to AVP and to 0 mm
Table 2. Values of intracellular pH under basal conditions and in the
presence of ANP (10- M) and amiloride (l0- at), in HEPES medium
0 mm 5 mm 10 mm
Control (N = 6) 7.28 0.05 7.27 0.03 7.28 0.03
ANP (10 M) 7.29 0.03 7.20 0.03 7.16 o.o2(N =8)
Amiloride (l0— at) 7.26 0,02 7.19 0.02 7.15 0.02a(N=8)
a P < 0.05 with respect to time 0 in HEPES medium
cells, in 4 different experiments). No further experiments were
done in this type of medium in the presence of ANP, cGMP or
amiloride, since results showing the inhibition of AVP-induced
shape change by ANP, cGMP and amiloride have appeared
previously [4, 6]. Further shape-change studies were conducted
in C03H/C02 medium to elucidate the role of the inhibition of
the intracellular alkalinization phase after exposure to AVP in
the presence of ANP, in the inhibition of VSMC shape change.
In C03H/C02 buffer, the shape change with AVP (10-8 M)
alone, and in the presence of AVP + ANP (l0— M) or AVP +
HMA (l0 M) were 25.3 3.5, 12.7 3.9 and 14.9 3.5,
respectively, (N 150 in 6 different experiments, N = 144 in 6
different experiments, N = 116 in 6 different experiments,
respectively, P < 0.05 with respect to the control for both ANP
and HMA).
Time, seconds
Fig. 10. Effect of ANP on the pH, recovery after exposure of the cells
to nigericin (2 x 10 M) in pH 6.8, KG! buffer, washing and reintro-
duction of PSS, pH 7.4. Symbols are: (U) control; (•) ANP.
I
a
ci)
C
7.6
Time, minutes
Fig. 11. Effect of cGMP on the recovery from an acid load. Symbols
are: (•)PSS-Ca; (U) IBMX; (A) 10b0 ANP; (D)10_to ANP + IBMX;(0) l0 ANP. Cells were incubated in pH 6.6 PSS for 20 mm and
rapidly (<10 sec) transferred to pH 7.4 PSS. Both curves are signifi-
cantly different from the 30 sec measurements. *p < 0.05.
Table 1. Values of intracellular pH after AVP (l0 M) stimulation
and in the simultaneous presence of ANP (I0- M) or HMA (10 M),
in C03H/CO-, medium
pHi
I0.
7.4
7.3
7.2
7.1
7.0
6.9
6.8
6.7
0 20 40 60 120 180 200
7.5
7.3
I 7.1
6.9
6.7
0 20 40 60 120 200 220
Time, seconds
Fig. 9. Effect of ANP on the pHi recovery after exposure of VSMC to
a pulse of ammonium chloride (20 mM). Symbols are: (U) control; (•)
ANP. *< 0.005.
7.4
7.2
7.0
6.8
6.6
0 1 2 3 4 5
Effects of ANP and amiloride analogues on AVP binding
The effect of ANP to decrease the AVP-induced rise in
VSMC pH occurred in the absence of an effect on AVP binding.
Specific 3H-AVP binding in basal conditions was 8014 278
cpm mg protein'' and was 7913 228 cpm mg protein in
the presence of ANP (l0 M) (P = NS, N = 3). Also, the
addition of HMA did not produce detectable effects on AVP
binding (binding in the presence of 10 M HMA = 95 4% of
the AVP binding in the absence of HMA; P = NS). These latter
results are in agreement with those reported by Thibonnier et a!
[35].
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Time, seconds
Fig. 12. Effect of the phosphodiesterase inhibitor, IBMX, on the con-
centration-response toANP. Symbols are: (0) control; (•) cGMP (10—a
M). The experimental model used included pH 6.8 + nigericin acidifi-
cation and subsequent reintroduction of pH 7.4 PSS, as shown in Figure
10. A markedly different response (P < 0.001) was obtained with 100
M ANPdepending or not of the presence or absence of IBMX (0.5mM).
Discussion
Studies from our laboratory demonstrated that atriopeptin III
inhibited AVP-induced VSMC contraction, an effect which was
associated with a decrease in [Ca2]1 [4]. Atriopeptin III also
stimulated cGMP formation in a dose-response manner in
VSMC and 8-bromo cGMP decreased the effect of AVP to
increase [Ca2], [4]. While these results provided evidence for
the initial cellular contractile mechanism whereby ANP blocks
the effect of vasoconstrictor agents, the more sustained effect
on VSMC contraction involves additional cellular mechanisms.
In this regard, ANP was shown to attenuate the effect of AVP
to stimulate Ca2 uptake by VSMC [4]. Since AVP-induced
sustained contraction is Ca2-dependent and is accompanied by
22Na uptake [281 and by stimulation of Na/H exchange
[13—15, 34], the present studies were undertaken to evaluate the
effect of ANP and cGMP on Na/H exchange. The potential
effect of ANP and its second messenger, cGMP, was studied by
examining the effect of inhibitors of Na/H exchange on
VSMC Na uptake, intracellular pH and shape change in
VSMC. Our results demonstrate, by Na uptake, pH change by
hormones and recovery from intracellular acidification, that
ANP/cGMP interfere with VSMC Na/H exchange. The
results obtained by several complementary methods disclosed
that both hormone-stimulated and pH-stimulated pathways of
Na/H exchange activation were equally affected.
It is reasonable to suggest an effect of ANP on the Na/H
antiporter since such an effect has been demonstrated in epi-
thelial tissues [7—9]. O'Donnell et al have, however, failed to
find such an effect of ANP on Na/H exchange in VSMC [36].
Two facts may be responsible for the differences between
O'Donnell's results and ours: first, those previous studies were
performed in late passaged VSMC which may have diminished
cGMP-dependent protein kinase and thus a decrease of most of
cGMP-dependent functions [37, 38], whereas the present study
was undertaken in early passaged VSMC. Second, O'Donnell et
al stimulated Na/H exchange with fetal calf serum, a maneu-
ver which may provoke multiple effects beyond NaiH stim-
ulation. Preliminary results by Brandes and Kleinman have also
disputed these previous findings by O'Donnell et al [39].
The present results demonstrated an effect of amioride to
decrease Na uptake by VSMC. Moreover, the effect of ANP
and cGMP to decrease VSMC Na uptake was not demonstra-
ble in the presence of amiloride. This effect of amioride could
be mediated by blocking one or more cellular Na transport
systems, including Na channels, Na/Ca2 channels or the
Na/H antiporter. A specific inhibitor of the Na/H an-
tiporter, namely HMA, was therefore used to investigate more
precisely the mechanism whereby ANP decreases Na trans-
port in VSMC. The effect of inhibition of the Na/H antiporter
on VSMC Na uptake was quantitatively similar to that ob-
served with ANP and cGMP. Moreover, the maximal effects of
ANP or cGMP were not additive to the effects of inhibition of
the Na/H antiporter with HMA. These results were therefore
compatible with a common mechanism of action for ANP and
cOMP on VSMC 22Na uptake. The more pronounced effect of
amiloride on VSMC 22Na uptake also indicates an effect on
Na transport in VSMC by mechanisms in addition to inhibi-
tion of the Na/H antiporter, such as blocking Na or
NaICa2 channels. The presence of an ANP effect from 30
seconds on the 22Na uptake, the increase in intracellular [H]
in the presence of ANP, and the absence of effect of ANP on
22Na efflux all suggest that the effect of ANP occurs predom-
inantly by alterating Na entrance and H extrusion.
Further studies were performed to examine the effect of ANP
and its secondary messenger on the Na/H antiporter by
measuring changes in VSMC pH. These studies were per-
formed using both HEPES-buffered PSS or C03H/C02 buffer.
In contrast to the HEPES buffer, bicarbonate-containing buff-
ers allow activation of the C1/HCO3- exchanger, which ob-
scures any effect of such maneuvers on VSMC pH [29]. On the
contrary, the use of HEPES buffer is useful to make the effect
of AVP on the Na/H antiporter more manifest, due to the
presence of an evident intracellular alkalimzation. In the
present studies, ANP significantly decreased the VSMC pH
response after challenging with AVP in both C03H/C02 or
HEPES-buffered media. A striking effect of ANP and cGMP
was noted also on the recovery to an intracellular H load,
which further supports the existence of a blockade by both
ANP and cGMP of the proton-extrusion mechanism. The
actions of ANP on AVP-stimulated and acidic pH-stimulated
H extrusion suggest that ANP acts on the Na/H antiporter
independently of the particular activation mechanism of this
exchanger.
Recent evidence [30, 40] supports a significant role of pH
changes in the regulation of AVP-induced VSMC contraction;
thus, the effect of ANP on intracellular pH may have a critical
importance for the VSMC relaxing effect of ANP. Our results in
which VSMC shape change was blocked by specific inhibition
of the Na/H antiporter by HMA and EIPA, provide further
support to the hypothesis that the activity of this Na/H
antiporter is important in the VSMC contractile effect of AVP.
The fact that both the AVP-mediated contractile effect as well
as the inhibition of shape change by ANP and HMA persisted in
CO3H/C02 medium suggests that Na/H antiporter inhibi-
tion rather than the intracellular alkalinization itself was the
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important phenomenon in regulating VSMC contraction. The
present results are in agreement with the previous observations
by Ganz et al [29] who have shown in studies examining
mesangial cell growth that the mitogenic effect of AVP is
equally present, independently of the presence (HEPES me-
dium) or the absence (C03H/C02 medium) of intracellular
alkalinization. Further experiments will be needed to address
the effect of the specific inhibition of Na/H antiporter on the
stimulation of other messenger and effector mechanisms, that
is, Ca2 mobilization, protein kinase C and phospholipase
activation and protein phosphorylation. It should be noted, as
shown by Thibonnier et al [35] and the present study, that
amiloride analogues do not reduce AVP binding to VSMC at the
concentrations used in the present experiments.
While these above studies support a role of ANP and its
second messenger, cGMP, to inhibit the Na/H antiporter in
VSMC, additional effects on Na transport are possible. ANP
has been shown not to alter Na/K-ATPase [22]; however, a
potential effect of ANP on the Na ,K ,Cl co-transporter was
theoretically possible. However, since the effects of ANP and
cGMP were additive with those of furosemide or bumetanide, it
is reasonable to assume that, at least in the conditions of the
present experiments, these compounds are acting on different
Na transport pathways.
In summary, in an earlier study an effect of ANP and its
second messenger were shown to diminish cellular Ca2 mobi-
lization in response to AVP. This effect occurs within seconds
of VSMC exposure to the pressor agent and is involved in the
initial phase of VSMC contraction. The later (minutes) phase of
sustained cell contraction, however, involves increased cellular
Ca2 uptake, protein kinase C activation and increased
Na/H antiporter activity. Moreover, the stimulation of pro-
tein kinase C with phorbol esters has been shown to cause
sustained VSMC contraction in the absence of a rise in [Ca2]
[6]. Since in addition to the effect of ANP to decrease the
pressor-induced rise in [Ca2]1, ANP was also shown to inhibit
sustained VSMC contraction and to decrease VSMC Ca2
uptake, the present results focused on the potential effect of this
hormone and its secondary messenger to alter Na transport in
VSMC. The results demonstrate an effect of both ANP and
cGMP to decrease VSMC Na uptake, an effect mimicked by a
specific Na/H inhibitor. The precise mechanism by which
ANP interacts with the Na/H antiporter may be related to its
effect on baseline [Ca2]1 and AVP-stimulated [Ca2i peak [4].
In this regard, Mitsuhashi and Ives [41] have demonstrated that
the activity of the Na/H antiporter is significantly related to
[Ca2]1 levels. The shape of the VSMC pH curve in the
presence of ANP and cGMP also suggests a change in the
aflnity of the intracellular H site of the Na/H antiporter, a
possibility in need of further study.
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